Comparison Xilio Therapeutics (XLO) with Competitors
Xilio Therapeutics (XLO) industry is Biotechnology.
Profit Margin
XLO-75.34%
Industry-0.77%
Upside-74.57%
Operating Margin
XLO-111.60%
Industry-2055.25%
Upside+1943.65%
P/E
XLO-1.13
Industry-20.52
Upside+1938.35%
P/S
XLO1.14
Industry10.01
Upside-88.66%
P/B
XLO0.84
Industry5.15
Upside-83.72%